Andrea Yu-Lin Ban, Paranthaman Vengadasalam, Sri Wahyu Taher, Mohd Arif Mohd Zim, Syazatul Syakirin Sirol Aflah, Ummi Nadira Daut, Irfhan Ali Hyder Ali, Lalitha Pereirasamy, Azza Omar, Aishah Ibrahim, Noor Aliza Mohd Tarekh, Swee Kim Chan, Norsiah Ali, Nor Azila Mohd Isa, Husni Hussain, Noraziah Abdul Karim, Vieshal Raja Gopal, Sue Yin Chiam, Maarten J H I Beekman
INTRODUCTION: SABINA III assessed short-acting β2 -agonist (SABA) prescription patterns and their association with asthma-related outcomes globally. Herein, we examined SABA prescription and clinical outcomes in the Malaysian cohort of SABINA III. METHOD: In this observational, cross-sectional study, patients (≥12 years) were recruited between July and December 2019 from 15 primary and specialty care centres in Malaysia. Prescribed asthma treatments and severe exacerbation history within 12 months prior and asthma symptom control during the study visit were evaluated...
2023: Malaysian Family Physician